Comparative Effectiveness in Terms of Treatment Discontinuation of Orodispersable Versus. Standard Oral Olanzapine Tablets in Non-Adherent Patients: Results from a 1-Year European Outpatient Observational Study.

Novick, D; Montgomery, W; Treuer, T; Aguado, J; Kraemer, S; Haro, J M

Novick, D; Montgomery, W; Treuer, T; Aguado, J; Kraemer, S; Haro, J M.

Affiliation

Novick D; Eli Lilly Holdings Limited, Windlesham, UK.
Montgomery W; Eli Lilly Australia Pty Ltd,, West Ryde, Australia.
Treuer T; Eli Lilly & Company, Budapest, Hungary.
Aguado J; Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain.
Kraemer S; Eli Lilly and Company Ltd, Bad Homburg, Germany.
Haro JM; Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain.

Value Health ; 17(7): A766, 2014 Nov.

Article in En | MEDLINE | ID: mdl-27202812

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2014 Document type: Article Affiliation country: United kingdom Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google